Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG–PCLNanoparticles

References

• Lv L, Qiu K, Yu X, et al. Amphiphilic copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast cancer. J Biomed Nanotechnol. 2016;12:973–985.
   PubMed Web of Science ®Google Scholar
• Kheiri Manjili H, Sharafi A, Attari E, et al. Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL–PEG–PCL copolymeric-based micelles. Artif Cells Nanomed Biotechnol. 2017[Feb 1];[1–12]. [Epub ahead of print]. doi: 10.1080/21691401.2017.1282501
   PubMed Web of Science ®Google Scholar
• Yang Q, Yu X, Li T, et al. Hemoglobin-loaded triblock PCLA-PEG-PCLA copolymer vesicles: a potential oxygen carrier. J nanosci nanotechnol. 2016;16:6734–6740.
   Web of Science ®Google Scholar
• Laskar P, Saha B, Ghosh SK, et al. PEG based random copolymer micelles as drug carriers: the effect of hydrophobe content on drug solubilization and cytotoxicity. RSC Adv. 2015;5:16265–16276.
   Web of Science ®Google Scholar
• Xiao W, Chen X, Yang L, et al. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. Int J Pharm. 2010;393:119–126.
   PubMed Web of Science ®Google Scholar
• Laskar P, Samanta S, Ghosh SK, et al. In vitro evaluation of pH-sensitive cholesterol-containing stable polymeric micelles for delivery of camptothecin. J Colloid Interface Sci. 2014;430:305–314.
   PubMed Web of Science ®Google Scholar
• Laskar P, Dey J, Ghosh SK. Evaluation of zwitterionic polymersomes spontaneously formed by pH-sensitive and biocompatible PEG based random copolymers as drug delivery systems. Colloids Surf B Biointerfaces. 2016;139:107–116.
   PubMed Web of Science ®Google Scholar
• Liu D, Yang F, Xiong F, et al. The smart drug delivery system and its clinical potential. Theranostics. 2016;6:1306–1323.
   PubMed Web of Science ®Google Scholar
• Fan L, Li F, Zhang H, et al. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. Biomaterials. 2010;31:5634.
   PubMed Web of Science ®Google Scholar
• Laskar P, Dey J, Banik P, et al. In vitro drug and gene delivery using random cationic copolymers forming stable and pH-sensitive polymersomes. Macromol Biosci. 2017. [Epub ahead of print]. doi: 10.1002/mabi.201600324
   PubMed Web of Science ®Google Scholar
• Laskar P, Dey J, Ghosh SK. Spontaneously formed redox- and pH-sensitive polymersomes by mPEG based cytocompatible random copolymers. J Colloid Interface Sci. 2017;501:22–33.
   PubMed Web of Science ®Google Scholar
• Danafar H, Rostamizadeh K, Davaran S, et al. Drug-conjugated PLA–PEG–PLA copolymers: a novel approach for controlled delivery of hydrophilic drugs by micelle formation. Pharm Dev Technol. 2015. [Epub ahead of print]. doi: 10.3109/10837450.2015.1125920
   Google Scholar
• Zhang J, Wu D, Feng J. One-step way to form prodrug micelles with high amount drug loading. J Nanosci Nanotechnol. 2016;16:5586–5591.
   PubMed Web of Science ®Google Scholar
• Wang YLi, Zhao H, Peng JRong, et al. Targeting therapy of neuropilin-1 receptors overexpressed breast cancer by paclitaxel-loaded CK3-conjugated polymeric micelles. J Biomed Nanotechnol. 2016;12:2097–2111.
   PubMed Web of Science ®Google Scholar
• Lage H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents. 2003;22:188–199.
   PubMed Web of Science ®Google Scholar
• Elkhodiry MA, Momah CC, Suwaidi SR, et al. Synergistic nanomedicine: passive, active and ultrasound-triggered drug delivery in cancer treatment. J Nanosci Nanotechnol. 2016;16:1–18.
   PubMed Web of Science ®Google Scholar
• Tang HD, Murphy CJ, Shen YQ, et al. Amphiphilic curcumin conjugate-forming nanoparticles as anticancerprodrug and drug carriers: in vitro and in vivo effects. Nanomedicine. 2010;5:855–865.
   PubMed Web of Science ®Google Scholar
• Manjili HK, Ghasemi P, Malvandi H, et al. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. Eur J Pharm Biopharm. 2017;116:17–30.
   PubMed Web of Science ®Google Scholar
• Danafar H, Rostamizadeh K, Hamidi M. Polylactide/Poly(ethylene glycol)/Polylactide triblock copolymer micelles as carrier for delivery of hydrophilic and hydrophobic drugs: a comparison study. Int J Pharm Investig. 2017. [Epub ahead of print]. doi: 10.1007/s40005-017-0334-8
   Google Scholar
• Notarbartolo M, Poma P, Perri D, et al. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-B activation levels and in IAP gene expression. Cancer Lett. 2005;1:53–65.
   Web of Science ®Google Scholar
• Zhu Y, Liao L. Applications of nanoparticles for anticancer drug delivery: a review. J Nanosci Nanotechnol. 2015;15:4753–4773.
   PubMed Web of Science ®Google Scholar
• Yang Y, QingFa G, JinRong P, Jing S, XiaoLing L, YongXiang Z, ZhiYong Q. Doxorubicin-conjugated heparin-coated superparamagnetic iron oxide nanoparticles for combined anticancer drug delivery and magnetic resonance imaging. J Biomed Nanotechnol. 2016;12:1963–1974.
   PubMed Web of Science ®Google Scholar
• Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 2002;244:127–135.
   PubMed Web of Science ®Google Scholar
• Danafar H. Study of the composition of polycaprolactone/poly (Ethylene Glycol)/polycaprolactone copolymer and drug-to-polymer ratio on drug loading efficiency of curcumin to nanoparticles. J Nat Pharm Prod. 2016. [Epub ahead of print]. doi: 10.17795/jjnpp-34179
   Google Scholar
• Liwei T, Buyun M, Qian Z, et al. Toxicity evaluation and anti-tumor study of docetaxel loaded mPEG-polyester micelles for breast cancer therapy. J Biomed Nanotechnol. 2017;13:393–408.
   Web of Science ®Google Scholar
• Cheng T, Liu J, Ren J, et al. Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance. Theranostics. 2016;6:1277–1292.
   PubMed Web of Science ®Google Scholar
• Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm. 2009;6:928–939.
   PubMed Web of Science ®Google Scholar
• Danafar H, Sharafi A, Kheiri Manjili H, et al. Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells. Pharm Dev Technol. 2017;22:642–651.
   PubMed Web of Science ®Google Scholar
• Gharebaghi F, Dalali N, Ahmadi E, et al. Preparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cells. J Biomater Appl. 2017;31:1305–1316.
   PubMed Web of Science ®Google Scholar